SIEGE
Research type
Research Study
Full title
Scheduling nab-paclItaxEl with GEmcitabine (SIEGE): Randomised phase II trial to investigate two different schedules of nab-paclitaxel (Abraxane) combined with gemcitabine as first line treatment for metastatic pancreatic ductal adenocarcinoma
IRAS ID
130640
Contact name
Pippa Corrie
Contact email
Sponsor organisation
Cambridge University Hospitals NHS Foundation Trust
Eudract number
2013-001868-40
REC name
HSC REC B
REC reference
13/NI/0143
Date of REC Opinion
1 Nov 2013
REC opinion
Further Information Favourable Opinion